Botanical Drug Extracts Combined With Biomaterial Carriers for Osteoarthritis Cartilage Degeneration Treatment: A Review of 10 Years of Research

Overview

Journal Front Pharmacol

Date 2022 Feb 17

PMID 35173609

Authors

Panyun Mu

Jie Feng

Yimei Hu

Feng Xiong

Xu Ma

Linling Tian

Affiliations

Soon will be listed here.

Abstract

Osteoarthritis (OA) is a long-term chronic arthrosis disease which is usually characterized by pain, swelling, joint stiffness, reduced range of motion, and other clinical manifestations and even results in disability in severe cases. The main pathological manifestation of OA is the degeneration of cartilage. However, due to the special physiological structure of the cartilage, once damaged, it is unable to repair itself, which is one of the challenges of treating OA clinically. Abundant studies have reported the application of cartilage tissue engineering in OA cartilage repair. Among them, cell combined with biological carrier implantation has unique advantages. However, cell senescence, death and dedifferentiation are some problems when cultured . Botanical drug remedies for OA have a long history in many countries in Asia. In fact, botanical drug extracts (BDEs) have great potential in anti-inflammatory, antioxidant, antiaging, and other properties, and many studies have confirmed their effects. BDEs combined with cartilage tissue engineering has attracted increasing attention in recent years. In this review, we will explain in detail how cartilage tissue engineering materials and BDEs play a role in cartilage repair, as well as the current research status.

Citing Articles

Edge advances in nanodrug therapies for osteoarthritis treatment.

Liao J, Gu Q, Liu Z, Wang H, Yang X, Yan R Front Pharmacol. 2024; 15:1402825.

PMID: 39539625 PMC: 11559267. DOI: 10.3389/fphar.2024.1402825.

Astaxanthin mediated repair of tBHP-Induced cellular injury in chondrocytes.

Liang W, Liu G, Zhou W, Chen W, Lu Y, Wu H Redox Rep. 2024; 29(1):2422271.

PMID: 39495906 PMC: 11536701. DOI: 10.1080/13510002.2024.2422271.

Phytochemical Compounds Involved in the Bone Regeneration Process and Their Innovative Administration: A Systematic Review.

Hanga-Farcas A, Miere Groza F, Filip G, Clichici S, Fritea L, Vicas L Plants (Basel). 2023; 12(10).

PMID: 37653972 PMC: 10222459. DOI: 10.3390/plants12102055.

A Bibliometric and Knowledge Map Analysis of Osteoarthritis Signaling Pathways from 2012 to 2022.

Li B, Zheng J J Pain Res. 2022; 15:3833-3846.

PMID: 36510617 PMC: 9738985. DOI: 10.2147/JPR.S385482.

Ginkgolide C slows the progression of osteoarthritis by activating Nrf2/HO-1 and blocking the NF-κB pathway.

Ma T, Jia L, Zhao J, Lv L, Yu Y, Ruan H Front Pharmacol. 2022; 13:1027553.

PMID: 36386227 PMC: 9651149. DOI: 10.3389/fphar.2022.1027553.

References

Parhiz H, Roohbakhsh A, Soltani F, Rezaee R, Iranshahi M . Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytother Res. 2014; 29(3):323-31. DOI: 10.1002/ptr.5256. View

Frehner F, Benthien J . Microfracture: State of the Art in Cartilage Surgery?. Cartilage. 2017; 9(4):339-345. PMC: 6139587. DOI: 10.1177/1947603517700956. View

Xia B, Chen D, Zhang J, Hu S, Jin H, Tong P . Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif Tissue Int. 2014; 95(6):495-505. PMC: 4747051. DOI: 10.1007/s00223-014-9917-9. View

Zhao X, Peng C, Zhang H, Qin L . Sinomenium acutum: a review of chemistry, pharmacology, pharmacokinetics, and clinical use. Pharm Biol. 2012; 50(8):1053-61. DOI: 10.3109/13880209.2012.656847. View

Burt H, Tsallas A, Gilchrist S, Liang L . Intra-articular drug delivery systems: Overcoming the shortcomings of joint disease therapy. Expert Opin Drug Deliv. 2009; 6(1):17-26. DOI: 10.1517/17425240802647259. View

Tasneem S, Liu B, Li B, Choudhary M, Wang W . Molecular pharmacology of inflammation: Medicinal plants as anti-inflammatory agents. Pharmacol Res. 2018; 139:126-140. DOI: 10.1016/j.phrs.2018.11.001. View

Jiang W, Fan W, Gao T, Li T, Yin Z, Guo H . Analgesic Mechanism of Sinomenine against Chronic Pain. Pain Res Manag. 2020; 2020:1876862. PMC: 7225909. DOI: 10.1155/2020/1876862. View

Aggarwal B, Gupta S, Sung B . Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol. 2013; 169(8):1672-92. PMC: 3753829. DOI: 10.1111/bph.12131. View

Pan L, Zhang Y, Chen N, Yang L . Icariin Regulates Cellular Functions and Gene Expression of Osteoarthritis Patient-Derived Human Fibroblast-Like Synoviocytes. Int J Mol Sci. 2018; 18(12). PMC: 5751258. DOI: 10.3390/ijms18122656. View

10.

Chen Y, Tsai K, Chan D, Lan K, Chen C, Yang R . Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes. J Orthop Res. 2013; 32(4):573-80. DOI: 10.1002/jor.22577. View

11.

Heinecke L, Grzanna M, Au A, Mochal C, Rashmir-Raven A, Frondoza C . Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate. Osteoarthritis Cartilage. 2009; 18(2):220-7. DOI: 10.1016/j.joca.2009.08.015. View

12.

Rasheed Z, Rasheed N, Al-Shobaili H . Epigallocatechin-3-O-gallate up-regulates microRNA-199a-3p expression by down-regulating the expression of cyclooxygenase-2 in stimulated human osteoarthritis chondrocytes. J Cell Mol Med. 2016; 20(12):2241-2248. PMC: 5134388. DOI: 10.1111/jcmm.12897. View

13.

Javadi F, Eghtesadi S, Ahmadzadeh A, Aryaeian N, Zabihiyeganeh M, Rahimi Foroushani A . The effect of quercetin on plasma oxidative status, C-reactive protein and blood pressure in women with rheumatoid arthritis. Int J Prev Med. 2014; 5(3):293-301. PMC: 4018638. View

14.

Gong Y, Gluud C . Colchicine for primary biliary cirrhosis. Cochrane Database Syst Rev. 2004; (2):CD004481. DOI: 10.1002/14651858.CD004481.pub2. View

15.

Ahmed S, Rahman A, Hasnain A, Lalonde M, Goldberg V, Haqqi T . Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med. 2002; 33(8):1097-105. DOI: 10.1016/s0891-5849(02)01004-3. View

16.

Lecanda F, Avioli L, Cheng S . Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem. 1997; 67(3):386-96. View

17.

Tang Y, Li Y, Xin D, Chen L, Xiong Z, Yu X . Icariin alleviates osteoarthritis by regulating autophagy of chondrocytes by mediating PI3K/AKT/mTOR signaling. Bioengineered. 2021; 12(1):2984-2999. PMC: 8806900. DOI: 10.1080/21655979.2021.1943602. View

18.

Ashraf S, Radhi M, Gowler P, Burston J, Gandhi R, Thorn G . The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritis. Sci Rep. 2019; 9(1):4696. PMC: 6423048. DOI: 10.1038/s41598-019-41140-1. View

19.

Mohamed A, Elmotasem H, Salama A . Colchicine mesoporous silica nanoparticles/hydrogel composite loaded cotton patches as a new encapsulator system for transdermal osteoarthritis management. Int J Biol Macromol. 2020; 164:1149-1163. DOI: 10.1016/j.ijbiomac.2020.07.133. View

20.

Zeng L, Yu G, Hao W, Yang K, Chen H . The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis. Biosci Rep. 2021; 41(6). PMC: 8202067. DOI: 10.1042/BSR20210817. View